NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 2 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $9,000 | -55.0% | 32,000 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $20,000 | -9.1% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $22,000 | +10.0% | 32,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $20,000 | +100.0% | 32,000 | +166.7% | 0.00% | 0.0% |
| Q3 2014 | $10,000 | +11.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $9,000 | -35.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $14,000 | -6.7% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $15,000 | -28.6% | 12,000 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $21,000 | +23.5% | 12,000 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $17,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 1,000,000 | $630,000 | 0.56% |
| Orbitronix, LP | 309,800 | $214,000 | 0.12% |
| GARRISON BRADFORD & ASSOCIATES INC | 142,000 | $98,000 | 0.09% |
| WEDBUSH SECURITIES INC | 297,076 | $205,000 | 0.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 34,679 | $29,000 | 0.01% |
| Polar Asset Management Partners Inc. | 300,000 | $202,000 | 0.01% |
| GLENMEDE TRUST CO NA | 300,000 | $207,000 | 0.00% |
| RONALD BLUE & CO LLC | 32,000 | $22,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 59,623 | $41,000 | 0.00% |
| MORGAN STANLEY | 2,500 | $2,000 | 0.00% |